Tag: Research

PTSD: Agony and Ecstasy

In November of 2016, the US Food and Drug Administration (FDA) gave permission for the commencement of large-scale Phase 3 clinical trials into the use of MDMA (Ecstasy) in the treatment of PTSD. If successful, the trials could see an illicit street substance become a potent treatment for PTSD by 2021. Post-Traumatic Stress Disorder (PTSD) …

Kratom: Medicinal or Criminal

The U.S. Drug Enforcement Agency (DEA) moved earlier this year to list the herbal supplement kratom as a Schedule 1 drug under the Controlled Substances Act. This would place kratom alongside Heroin, LSD, Morphine, and Ice as substances that have a high potential for abuse and a risk to public health. The ban, proposed to …

Substance Use Disorder (SUD)

Alcohol and drug misuse and related disorders are major public health challenges that are taking an enormous toll on individuals, families, and society. Neighborhoods and communities as a whole are also suffering as a result of alcohol- and drug-related crime and violence, abuse and neglect of children, and the increased costs of health care associated …

New Research Shows Benefits of High-Intensity Statins

In a study publishing this week in JAMA Cardiology, Stanford researchers show that taking high-intensity statins could increase heart patients’ chances of survival over taking moderate-intensity statins. There are currently seven main types of statins prescribed in the United States. A set of guidelines put forth by the American College of Cardiology and the American Heart …

Research into Complementary Medicines

A new multimillion dollar deal between Swisse Wellness and CSIRO has raised questions about the integrity of Australia’s premier scientific research organisation and the motivations behind the deal. Another important question is whether consumers will benefit from such partnerships. Swisse manufactures complementary and alternative medicines, which are widely used by different populations.